MN Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,770
Closed -$303K 134
2025
Q4
$303K Sell
13,770
-3,660
-21% -$66.1K 0.15% 90
2025
Q3
$212K Buy
+17,430
New +$236K 0.11% 110
2025
Q2
Sell
-10,623
Closed -$204K 118
2025
Q1
$204K Sell
10,623
-7,331
-41% -$215K 0.12% 100
2024
Q4
$647K Buy
17,954
+1,106
+7% +$37.4K 0.36% 58
2024
Q3
$715K Buy
16,848
+2,125
+14% +$90.1K 0.41% 48
2024
Q2
$593K Buy
14,723
+440
+3% +$18.4K 0.34% 55
2024
Q1
$506K Sell
14,283
-10,850
-43% -$291K 0.31% 63
2023
Q4
$743K Buy
+25,133
New +$521K 0.51% 47

Other funds holding TNDM

MN Wealth Advisors's TNDM Position: Q1 2026 in Review

MN Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 13,770 shares — an estimated $303K sold.

MN Wealth Advisors first reported a position in TNDM in Q4 2023 and held it in 8 quarters. The position peaked at $743K in Q4 2023. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • MN Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • MN Wealth Advisors sold 13,770 Tandem Diabetes Care shares in Q1 2026, an estimated $303K.
  • MN Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 8 quarters.
  • MN Wealth Advisors's Tandem Diabetes Care position peaked at $743K in Q4 2023.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on MN Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.